The Risperidone Market is set for transformative growth, with strategic insights revealing that leading players will significantly enhance their market share by 2035. The market, currently valued at 7.49 USD in 2024, is projected to grow at a 3.47% CAGR, reaching an estimated 10.9 USD by the forecast period's end. This trajectory highlights an increasing demand for mental health treatments...